CIK 0001551306
- Large accelerated filer
Progyny, Inc.
Sign in to watch- Ticker
- PGNY
- Exchange
- Nasdaq
- Industry
- Services-Misc Health & Allied Services, NEC
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 272220139
- Phone
- +1 212-888-3124
- Business address
- 1359 BROADWAY, 2ND FLOOR, NEW YORK, NY, 10018
- Former names
- Auxogyn, Inc., Auxogyn Inc
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $22,674,844
- in 10 filings, $22.0M under 10b5-1 plans
Net −$22,674,844. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-02-01 | Sturmer Michael E PRESIDENT | Sale 10b5-1 | −1,880 | $37.89 | $71K | 165,307 |
| 2024-02-01 | Sturmer Michael E PRESIDENT | Sale 10b5-1 | −4,515 | $37.89 | $171K | 160,792 |
| 2024-02-01 | Schlanger David J Executive Chairman | Exercise or conversion 10b5-1 | +30,000 | $3.95 | $119K | 116,312 |
| 2024-02-01 | Schlanger David J Executive Chairman | Sale 10b5-1 | −17,742 | $38.01 | $674K | 98,570 |
| 2024-02-01 | Schlanger David J Executive Chairman | Sale 10b5-1 | −12,258 | $38.69 | $474K | 86,312 |
| 2024-02-01 | Schlanger David J Executive Chairman | Exercise or conversion · Stock Option (Right to Buy) 10b5-1 | −30,000 | 1,440,022 | ||
| 2024-01-08 | Schlanger David J Executive Chairman | Exercise or conversion 10b5-1 | +66,002 | $3.95 | $261K | 152,314 |
| 2024-01-08 | Schlanger David J Executive Chairman | Sale 10b5-1 | −66,002 | $37.88 | $2.5M | 86,312 |
| 2024-01-08 | Schlanger David J Executive Chairman | Exercise or conversion · Stock Option (Right to Buy) 10b5-1 | −66,002 | 1,470,022 | ||
| 2024-01-02 | Livingston Mark S. CHIEF FINANCIAL OFFICER | Exercise or conversion 10b5-1 | +22,000 | $3.95 | $87K | 71,871 |
| 2024-01-02 | Livingston Mark S. CHIEF FINANCIAL OFFICER | Shares withheld for taxes 10b5-1 | −12,632 | $36.59 | $462K | 59,239 |
| 2024-01-02 | Livingston Mark S. CHIEF FINANCIAL OFFICER | Sale 10b5-1 | −9,368 | $36.52 | $342K | 49,871 |
| 2024-01-02 | Livingston Mark S. CHIEF FINANCIAL OFFICER | Sale 10b5-1 | −3,000 | $36.81 | $110K | 46,871 |
| 2024-01-02 | Livingston Mark S. CHIEF FINANCIAL OFFICER | Exercise or conversion · Stock Option (Right to Buy) 10b5-1 | −22,000 | 64,627 | ||
| 2024-01-02 | Sturmer Michael E PRESIDENT | Sale 10b5-1 | −1,880 | $36.81 | $69K | 171,702 |
| 2024-01-02 | Sturmer Michael E PRESIDENT | Sale 10b5-1 | −4,515 | $36.81 | $166K | 167,187 |
| 2024-01-02 | Anevski Peter CHIEF EXECUTIVE OFFICER | Shares withheld for taxes | −5,866 | $37.18 | $218K | 255,291 |
| 2024-01-02 | Schlanger David J Executive Chairman | Exercise or conversion 10b5-1 | +13,998 | $3.95 | $55K | 102,437 |
| 2024-01-02 | Schlanger David J Executive Chairman | Sale 10b5-1 | −13,998 | $37.58 | $526K | 88,439 |
| 2024-01-02 | Schlanger David J Executive Chairman | Shares withheld for taxes 10b5-1 | −2,127 | $37.18 | $79K | 86,312 |
Page 16 of 77 · 1,524 trades